ArticleThe Lancet regional health. Europe2026

Cost-effectiveness of lenacapavir versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual, and other men who have sex with men in Spain.

Philip Erick Wikman-Jorgensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.